Report Highlights
The global market for mobile apps for DNA sequencing was valued at an estimated $777.1 million in 2025 and is estimated to increase from $934.9 million in 2026 to reach $2.4 billion by the end of 2031, at a compound annual growth rate (CAGR) of 21.1% from 2026 to 2031.
Report Includes
- 33 data tables and 34 additional tables
- An analysis of the global markets for mobile apps for DNA sequencing data analysis
- Analyses of the global market trends, with historic data from 2023 to 2025, estimates for 2026 and projections of CAGRs through 2031
- Estimates of the market size and revenue prospects for the global market, accompanied by a market share analysis based on application platform, sequencing technology, end user, and region
- Facts and figures pertaining to the market dynamics, recent technological advancements in diabetes management, regulations, prospects and the impact of macroeconomic variables
- Insights derived from Porter’s Five Forces model, as well as global supply chain analyses
- Review of emerging technologies, market applications, industry structure, and key initiatives in clinical sequencing
- Patent review, featuring key granted and published patents
- Analysis of the industry structure, including companies’ market shares and rankings, product mappings, strategic initiatives, M&A activity and a venture funding outlook
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Company profiles of major players within the industry including, Illumina Inc., Thermo Fisher Scientific Inc., Oxford Nanopore Technologies plc., and QIAGEN
Report Scope
The scope of the global mobile apps for DNA sequencing market includes several major domains:
- DNA sequencing technologies.
- Genomic data analysis and bioinformatics.
- Genetic visualization tools.
- Consumer genomics and genealogy.
- Family tree and ancestry mapping.
- Clinical diagnostics and precision medicine.
- Cloud-based genomic platforms.
The report provides an overview of the global mobile apps for DNA sequencing market and analyzes market trends. The report includes global revenue ($ million) for the base year data 2025 and estimated data for the forecast period 2026 through 2031. The market is segmented based on platform, technology type, end-use, and regions. The regions covered in this study include North America, Europe, Asia-Pacific, and the Rest of the World, focusing on major countries in these regions.
The report focuses on the driving trends and challenges that affect the market and vendor landscape. It discusses emerging technologies related to the market. The report concludes with an analysis of the competitive landscape, which provides the ranking of key participants in the global mobile apps for DNA sequencing market. The company profiles section covers details such as overview, key financials, product portfolio, and recent developments of key market participants.
Report Synopsis
| Report Metrics | Details | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2025 | ||||||||||||
| Forecast period considered | 2026-2031 | ||||||||||||
| Base year market size | $777.1 million | ||||||||||||
| Market size forecast | $2.4 billion | ||||||||||||
| Growth rate | CAGR of 21.1% for the forecast period of 2026-2031 | ||||||||||||
| Units considered | $ Millions | ||||||||||||
| Segments covered | By Platform, By Technology Type, By End Use, By Region | ||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Rest of the World (South America, and Middle East and Africa) | ||||||||||||
| Countries covered | U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Switzerland, Denmark, Norway, Poland, Belgium, Austria, the Netherlands, Sweden, Russia, China, India, Japan, South Korea, Australia, New Zealand, Taiwan, Singapore, Malaysia, Thailand, the Philippines, Indonesia, Brazil, South Africa, Argentina, Israel, UAE, Egypt, Turkey, Iran, Iraq, Peru, and Columbia | ||||||||||||
| Key Market Drivers |
|
||||||||||||
| Companies studied |
|
||||||||||||
Frequently Asked Questions (FAQs)
- Rising adoption of portable sequencing devices.
- Advancements in cloud computing and AI.
- Declining cost of DNA sequencing.
- Growing investment in genomics and biotechnology research.
- Key challenges include- Data privacy and security concerns; Limited mobile processing capabilities; Interoperability issues.
- Key opportunities include- Growth in emerging markets; Expansion into point-of-care diagnostics.
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Related Reports
Mobile Health (mHealth) Technologies and Global Markets
The global market for Mobile Health (mHealth) Technologies is expected to grow from $91.4 billion in 2025 and is projected to reach $201.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 17.1% during the forecast period of 2025 to 2030.
The Chinese Market for DNA Sequencing
The Chinese DNA sequencing market is expected to grow from $1.2 billion in 2025 and is projected to reach $3.1 billion by the end of 2030, at a compound annual growth rate (CAGR) of 21.5% during the forecast period of 2025 to 2030.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Next-generation Sequencing: Emerging Clinical Applications and Global Markets
The global market for clinical applications of next-generation sequencing is estimated to increase from $21.9 billion in 2023 to reach $52.9 billion by 2028, at a compound annual growth rate (CAGR) of 19.3% from 2023 through 2028.
Track the Latest Global Tariff Developments
In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.
Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.
Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.
With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.
Ready to see what tariff means for your business?
Consult with our experts or request your custom Tariff Impact Brife today
Stay Informed, Stay Competitive
In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.
Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.
Our analysis includes:
- Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
- Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
- Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.
With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.
Don't let tariffs catch you off guard—let our insights guide your strategy.
Recent Reports
Mobile Apps for DNA Sequencing: Global Markets
The global market for mobile apps for DNA sequencing was valued at an estimated $777.1 million in 2025 and is estimated to increase from $934.9 million in 2026 to reach $2.4 billion by the end of 2031, at a compound annual growth rate (CAGR) of 21.1% from 2026 to 2031.
Agricultural Biotechnology: Emerging Technologies and Global Markets
The global agricultural biotechnology market was valued at an estimated $84.7 billion in 2025 and is estimated to increase from $91.5 billion in 2026 to reach $137 billion by the end of 2031, at a compound annual growth rate (CAGR) of 8.4% from 2026 to 2031.
Global Organoids and Spheroids Market
The report examines the global organoids and spheroids market, covering key trends, challenges, and market developments. It provides market estimates through 2031 and analyzes the market by product type, application, end user, and region. The study also looks at the use of organoids and spheroids in drug discovery, personalized medicine, disease studies, toxicity testing, developmental biology, and regenerative medicine. It covers major end users, including pharmaceutical and biotechnology companies, research institutes, CROs, hospitals, and diagnostic centers, along with the competitive landscape, market shares, and rankings of key businesses.
Gene Synthesis: Technologies and Global Markets
The global market for gene synthesis was valued at $3 billion in 2025 and is estimated to increase from $3.4 billion in 2026 to reach $7.2 billion by the end of 2031, at a compound annual growth rate (CAGR) of 16.1% from 2026 to 2031.
Global Peripheral Blood Mononuclear Cells (PBMCs) Market
The global market for peripheral blood mononuclear cells (PBMCs) was valued at $322.2 million in 2025 and, is estimated to reach $353.9 million by 2026 and $577.2 million by 2031, at a compound annual growth rate (CAGR) of 10.3% from 2026 through 2031.
Top Trending Reports
Bioinformatics: Technologies and Global Markets
The global bioinformatics market was valued at $23.5 billion in 2025 and is estimated to reach $43.5 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 to 2030.
Validation, Calibration, and Standardization in the Life Sciences Market
The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.
Power Infrastructure for Data Centers: Global Markets
This report provides a comprehensive analysis of global power infrastructure for data centers market, segmented by power infrastructure component, data center type, and end-use. It includes global revenue for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The report focuses on trends, challenges, and the competitive landscape, including market share of leading companies and company profiles with financials, product portfolios, and recent developments.
Lithium Batteries: Markets and Materials
The global lithium battery market was valued at $3.6 billion in 2025 and is estimated to increase from $3.7 billion in 2026 to reach $4.7 billion by the end of 2031, at a compound annual growth rate (CAGR) of 4.7% from 2026 to 2031.
Outpatient Surgical Procedures: Global Markets
The global market for outpatient surgical procedures is expected to grow from $381.9 billion in 2026 and is projected to reach $598.6 billion by the end of 2031, at a compound annual growth rate (CAGR) of 9.4% during the forecast period of 2026 to 2031.
Report Highlights
The global market for mobile applications for DNA sequencing reached $28.8 billion in 2017. The market should reach $248.3 billion by 2022, at a compound annual growth rate (CAGR) of 53.8% during 2017-2022.
Report Includes
- An in-depth analysis of the mobile applications of DNA sequencing, which is a developing personalized healthcare technique with enormous market potential.
- Analyses of market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
- A look at the current and future expectations regarding the cost of individual DNA mapping procedures
- Quantification of the DNA sequencing markets by product type, indication, and geography
- Insight into developers of apps, and how DNA mapping and apps combine to produce modern ways of recording information
- Comprehensive discussion covering DNA sequencing technologies, market applications, industry structure, and important clinical sequencing initiatives
- Patent analysis
- Company profiles of major players in the DNA sequencing sector, including 23andMe, Helix, Illumina, Thermo Fisher Scientific, and Roche
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More